Publication | Closed Access

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitisVirologyLiver DiseaseReal-world EfficacyMedicineEpidemiologyNationwide Multicenter Study